Michael D. West
2012 - BioTime
In 2012, Michael D. West earned a total compensation of $785K as Chief Executive Officer at BioTime, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $660,500 |
| Other | $24,500 |
| Total | $785,000 |
West received $660.5K in salary, accounting for 84% of the total pay in 2012.
West also received $100K in bonus and $24.5K in other compensation.
Rankings
In 2012, Michael D. West's compensation ranked 7,111th out of 11,487 executives tracked by ExecPay. In other words, West earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,111 out of 11,487 | 38th |
Division Manufacturing | 2,546 out of 4,253 | 40th |
Major group Chemicals And Allied Products | 651 out of 1,203 | 46th |
Industry group Drugs | 449 out of 925 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 74 out of 165 | 55th |
Source: SEC filing on June 11, 2015.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at BioTime in 2012.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019